Funding

Anthropic's $93.5B IPO debuts with 17% surge, then 20% tech rout wipeout

Share
Anthropic's $93.5B IPO debuts with 17% surge, then 20% tech rout wipeout

Anthropic's record $93.5B IPO surged 17% on debut, then fell sharply during Friday's broader tech rout. Markets are struggling with who captures AI's value and how long investors must wait.

TL;DR

  • Anthropic's $93.5B IPO saw a 17% surge followed by a sharp decline amid broader tech selloffs.
  • Isomorphic Labs raised $5B to advance AI-driven drug design, while other AI startups secured significant funding.
  • OpenAI released GPT-6.2 Astra and Sol, offering stronger professional performance at lower costs.

What happened

Anthropic's initial public offering (IPO) raised approximately $93.5 billion, including underwriters' additional shares, with the stock initially rising about 17% before falling sharply during a broader technology rout. The IPO included a concurrent $26 billion private placement to major tech companies, bringing the total to roughly $119.5 billion.

Isomorphic Labs, a DeepMind spinout, raised $5 billion in Series C funding co-led by Greenoaks and Sequoia Capital. The funding will support the scaling of its IsoDDE drug design engine and the advancement of its first AI-designed programs toward clinical trials.

OpenAI introduced GPT-6.2 Astra and GPT-6.2 Sol, with Astra's API input and output token prices reduced by 20%. These models emphasize stronger professional performance and greater efficiency, making them available in ChatGPT, Codex, and the API.

Why it matters

For developers and startups, the lower token prices for GPT-6.2 Astra could unlock new demand and make AI more accessible, though it may also put pressure on revenue per unit. This dual impact highlights the tension between AI adoption and profitability.

Investors are grappling with the valuation and timing of AI technologies. The market's reaction to Anthropic's IPO underscores the challenges in predicting the future cash flows of AI companies, even as the technology continues to advance.

The funding rounds for companies like Isomorphic Labs and Corma demonstrate the growing interest in AI applications across various sectors, from drug design to cybersecurity. These investments signal confidence in AI's potential to drive innovation and solve complex problems.

Key facts

  • Anthropic's IPO raised $93.5 billion, including underwriters' shares, and an additional $26 billion in a private placement, totaling $119.5 billion.
  • Isomorphic Labs secured $5 billion in Series C funding to scale its drug design engine and advance AI-designed programs toward clinical trials.
  • OpenAI's GPT-6.2 Astra and Sol models offer stronger professional performance at lower costs, with Astra's token prices reduced by 20%.
  • Corma, a defensive cybersecurity AI lab, raised $125 million in Series A funding at a $1 billion valuation.
  • Dreamteam, an AI-native CRM startup, raised $53 million to compete with Salesforce and HubSpot.
  • Model ML raised $250 million at a $1.5 billion valuation to provide personal AI agents for bankers, consultants, and investors.
  • Genesis AI raised $500 million at a $3.5 billion valuation to train robots using data from sensor gloves worn by human workers.

Context

The AI industry is experiencing rapid growth and innovation, with significant funding rounds and strategic investments. Companies like Anthropic, Isomorphic Labs, and OpenAI are at the forefront of this transformation, driving advancements in AI capabilities and applications.

The market's reaction to Anthropic's IPO highlights the challenges in valuing AI technologies and predicting their future impact. Investors are increasingly focused on the timing and capture of AI's value, as well as the potential for AI to drive economic growth and solve complex problems.

The release of GPT-6.2 Astra and Sol by OpenAI underscores the ongoing advancements in AI models, with a focus on professional performance and efficiency. These developments are reshaping the AI landscape and creating new opportunities for developers, startups, and investors.

Topics

Related coverage

Join the discussion

Have a take on this story? Weigh in with our community on Facebook.

💬 Discuss on Facebook →